539730
FREDUN
Invest Now
Start SIP in
FREDUN
Performance
- Low
- ₹848
- High
- ₹864
- 52 Week Low
- ₹635
- 52 Week High
- ₹904
- Open Price₹848
- Previous Close₹844
- Volume17,434
Investment Returns
- Over 1 Month + 7.77%
- Over 3 Month + 31.77%
- Over 6 Month + 22.8%
- Over 1 Year -0.19%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.5
- PEG Ratio
- 0.6
- Market Cap Cr
- 407
- P/B Ratio
- 3.1
- Average True Range
- 29.4
- EPS
- -
- Dividend Yield
- 0.1
- MACD Signal
- 20.09
- RSI
- 68.65
- MFI
- 69.23
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹861.50
+
17.25
(2.04%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹814.55
- 50 Day
- ₹777.48
- 100 Day
- ₹750.78
- 200 Day
- ₹749.11
Resistance and Support
857.48
- R3 883.22
- R2 873.73
- R1 866.97
- S1 850.72
- S2 841.23
- S3 834.47
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-30 | Audited Results & Dividend | |
2025-02-04 | Quarterly Results | |
2024-10-26 | Quarterly Results | |
2024-10-03 | Others | inter alia consider issue and allotment of Unsecured Foreign Currency ConvertibleBonds (FCCBs), in accordance with the provisions of the SEBI Regulations, 2018 and the Companies Act, 2013. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
2024-07-29 | Quarterly Results |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹861 As on 13 July, 2025 | 18:56
The Market Cap of Fredun Pharmaceuticals is ₹406.8 Cr As on 13 July, 2025 | 18:56
The P/E ratio of Fredun Pharmaceuticals is 19.5 As on 13 July, 2025 | 18:56
The PB ratio of Fredun Pharmaceuticals is 3.1 As on 13 July, 2025 | 18:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.